Mandatory notification of acquisition of shares by primary insider

Oslo, Norway, February 22, 2022 - Primary insider Martin Nicklasson, Chairman of the Board of Nykode Therapeutics AS, has today acquired 10,000 shares in Nykode Therapeutics AS at a price of NOK 42.00 per share. Following the transaction, Martin Nicklasson holds 22,000 shares in Nykode Therapeutics AS.

Please see further details in the attached document.